REGENXBIO

-$0.28 (-0.63%) As of 5:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.

About RGNX

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors; and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.

CEO
Kenneth T. Mills
Employees
306
Headquarters
Rockville, Maryland
Founded
2008

RGNX Key Statistics

Market Cap
1.91B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
716.78K
High Today
$45.00
Low Today
$42.93
Open Price
$44.98
Volume
313.65K
52 Week High
$50.26
52 Week Low
$25.93

RGNX News

BenzingaSep 15

Looking Into Regenxbio's Return On Capital Employed

Regenxbio (NASDAQ:RGNX) brought in sales totaling $22.04 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 18.58%, resul
BenzingaSep 13

Why Regenxbio Shares Are Trading Higher Today

Regenxbio Inc (NASDAQ: RGNX) is trading significantly higher Monday after the company, and AbbVie Inc (NYSE: ABBV), announced an eye care collaboration. The co
MarketWatchSep 13

AbbVie's deal to develop Regenxbio's investigational gene therapy could be worth $1.8 billion

Shares of AbbVie Inc. ABBV, -0.55% were up 0.8% in premarket trading on Monday after the drug maker announced a potential billion-dollar deal to develop and com

RGNX Earnings

-$1.36
-$0.83
-$0.30
$0.23
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, After Hours

More RGNX News

ReutersSep 13

UPDATE 1-AbbVie, Regenxbio enter deal to develop retinal disease therapy

(Adds details of deal) Sept 13 (Reuters) - AbbVie and Regenxbio Inc entered a partnership to develop and commercialize RGX-314, a gene therapy candidate for th
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure